Biodexa Pharmaceuticals (BDRX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
4.16
-0.08 (-1.89%)
At close: Jan 15, 2025, 11:24 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -0.24 | -10.51 | -57.22 | -13.21 | -26.06 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PS Ratio | 4.37 | 115.13 | 540.52 | 854.72 | 353.35 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.36 | 25.45 | 29.89 | 43.64 | 12.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
P/FCF Ratio | -0.23 | -11.32 | -49.37 | -30.83 | -34.98 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
P/OCF Ratio | -0.24 | -11.42 | -52 | -31.52 | -36.7 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
OCF/S Ratio | -17.92 | -10.08 | -10.39 | -27.12 | -9.63 | -6.94 | -13.1 | -9.89 | -9.03 | -34.75 | -30.18 | n/a |
Debt / Equity Ratio | 0.10 | 0.20 | 0.07 | 0.04 | 0.31 | 0.07 | 0.19 | 0.05 | 0.04 | 0.05 | 4.37 | n/a |
Quick Ratio | 1.39 | 2.47 | 6.39 | 3.56 | 2.42 | 2.27 | 2.11 | 2.30 | 2.18 | 11.17 | 1.78 | 0.22 |
Current Ratio | 1.26 | 2.47 | 6.39 | 3.10 | 2.42 | 2.27 | 2.22 | 2.39 | 2.23 | 11.17 | 1.78 | 0.22 |
Asset Turnover | 0.04 | 0.13 | 0.04 | 0.03 | 0.02 | 0.09 | 0.02 | 0.02 | 0.02 | 0.00 | 0.03 | n/a |
Interest Coverage | -195.46 | -168.53 | -159.05 | -313.85 | -116.68 | -20.13 | -108.04 | n/a | n/a | -47.92 | -18.14 | n/a |
Return on Equity (ROE) | -1.51 | -2.42 | -0.52 | -3.3 | -0.47 | -0.61 | -0.34 | -0.13 | -0.22 | -0.21 | -5.37 | 0.78 |
Return on Assets (ROA) | -0.67 | -1.39 | -0.42 | -2.26 | -0.3 | -0.51 | -0.24 | -0.11 | -0.16 | -0.19 | -0.79 | -1.8 |
Return on Capital (ROIC) | -1.61 | -2.46 | -0.63 | -1.56 | -0.45 | -0.66 | -0.29 | -0.2 | -0.18 | -0.18 | -1.56 | 1.41 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -967.45% | -631.19% | -705.19% | -1.67K% | -1.06K% | -382.92% | -742.16% | -484.28% | 94.91% | 100.00% | 100.00% | n/a |
Net Profit Margin | -1.86K% | -1.10K% | -944.64% | -6.47K% | -1.36K% | -534.98% | -1.18K% | -465.68% | -734.47% | -5.62K% | -2.78K% | n/a |
Pretax Profit Margin | -1.96K% | -1.21K% | -1.06K% | -6.84K% | -1.62K% | -639.83% | -1.31K% | -634.01% | -816.87% | -6.27K% | -3.32K% | n/a |
Operating Profit Margin | -2.10K% | -1.28K% | -1.21K% | -3.11K% | -1.68K% | -609.65% | -1.19K% | -729.55% | -733.96% | -4.91K% | -3.06K% | n/a |
FCF Margin | -1.86K% | -1.02K% | -1.09K% | -2.77K% | -1.01K% | -706.6% | -1.38K% | -1.09K% | -970.4% | -4.13K% | -3.05K% | n/a |
EBITDA Margin | -1.88K% | -1.06K% | -979.07% | -6.48K% | -1.42K% | -552.32% | -1.07K% | -400.76% | -762.91% | -5.96K% | -2.89K% | n/a |